IntroCann educates and empowers doctors to effectively incorporate medicinal cannabis as a component of patient treatment. 

Section 21 of the Medicines Act allows for the prescription of Medical Cannabis. IntroCann has automated and simplified the application process through the development of an online portal allowing for simple and seamless prescribing of this novel medication.
 
The application process adds no additional time to a patient consultation while opening up a brand-new prescribing category for doctors.

Recent Portal Updates: 

• Product Recommendation Tool: Selecting a suitable product for your patient is now even easier with our Product Recommendation Tool.
• Allowing the Patient to Pay: The payment step of the Section 21 Application can now be handed directly to the payment and will no longer need to be facilitated by the doctors. 

 Is Cannabis Right for your Patient? 

Medicinal Cannabis can be prescribed for: 

Chronic Pain 
This includes rheumatoid arthritis, osteoarthritis, psoriatic arthritis, trauma-induced chronic pain, fibromyalgia, and others. Successful section 21 applications have been made to the South African Health Products Regulatory Authority (SAHPRA) for chronic pain.

Spasticity 
This includes conditions like multiple sclerosis and amyotrophic lateral sclerosis which cause spasticity. Successful section 21 applications have been made to SAHPRA for spasticity.

Chemotherapy-Induced Nausea and Vomiting (CINV)
 Successful section 21 applications have been made to SAHPRA for CINV. 

Epilepsy
 Successful section 21 applications have been made to SAHPRA for epilepsy. 


Why Full-Spectrum, GMP Cannabis?  
The cannabis plant contains more than 100 terpene compounds that enhance the effect of cannabis described as the ‘entourage effect’. It is thus advisable to use full-spectrum medicinal cannabis over its synthetic or hemp-derived counterparts.